D
Bristol-Myers Squibb Company BMY
$59.01 -$1.27-2.11%
Recommendation
Sell
Prev Close
$60.28
Volume
11,905,738
Avg Vol (90D)
11,625,133
Market Cap
$122.33B
Dividend & Yield
$2.42(4.01%)
52-Week Range
$39.35 - $63.33
P/E (TTM)
--
EPS (TTM)
-$4.43
My Lists My Alerts
Rating
Reward
C
Fair
Risk
D
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Fair
Solvency Index
Good
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
Good
Headlines
MarketBeat Week in Review – 02/03 - 02/07
2/8/2025 - MarketBeat
12 Incredibly Cheap Dividend Stocks to Buy Now
3/15/2025 - Insider Monkey
Friday Sector Laggards: Consumer Products, Healthcare
3/14/2025 - Market News Video
Bristol-Myers Squibb (NYSE:BMY) Gets EC Nod For Breyanzi In NHL Treatment
3/14/2025 - Simply Wall St
Video: Friday's ETF Movers: SPXL, USCA
3/14/2025 - Market News Video
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell ...
3/14/2025 - GuruFocus
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
3/14/2025 - Business Wire
King Luther Capital Management Corp Has $1.25 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
3/14/2025 - Ticker Report
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Achmea Investment Management B.V.
3/14/2025 - Ticker Report
Essential Planning LLC. Takes $384,000 Position in Bristol-Myers Squibb (NYSE:BMY)
3/14/2025 - MarketBeat
Bristol Myers Squibb (BMY) Rises As Market Takes a Dip: Key Facts
3/13/2025 - Zacks Investment Research
Gilead (GILD) Up 10.3% Since Last Earnings Report: Can It Continue?
3/13/2025 - Zacks Investment Research
Analysts Offer Insights on Healthcare Companies: Ascend Wellness Holdings LLC (OtherAAWH), Bristol-Myers Squibb (BMY) and Caribou Biosciences (CRBU)
3/13/2025 - TipRanks Financial Blog
Biotech Stock Roundup: TSVT Up on BMY Deal, PTGX Up on Data & More
3/13/2025 - Zacks Investment Research
Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
3/13/2025 - GuruFocus
Bristol Myers Squibb to Report Results for First Quarter 2025 on April 24, 2025
3/13/2025 - Business Wire
Swiss National Bank Has $323.94 Million Holdings in Bristol-Myers Squibb (NYSE:BMY)
3/13/2025 - MarketBeat
Sequoia Financial Advisors LLC Purchases 8,745 Shares of Bristol-Myers Squibb (NYSE:BMY)
3/13/2025 - MarketBeat
Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)
3/12/2025 - SeekingAlpha
Bristol-Myers Squibb Company (BMY) Presents at Leerink Partners 2025 Global Healthcare Conference (Transcript)
3/12/2025 - Seeking Alpha: Transcripts
Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy According to Hedge Funds?
3/12/2025 - Insider Monkey
Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer
3/12/2025 - SeekingAlpha
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
3/12/2025 - Zacks Investment Research
Moors & Cabot Inc. Raises Position in Bristol-Myers Squibb (NYSE:BMY)
3/12/2025 - MarketBeat
Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
2/7/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$48.30B
EBITDA (TTM)
$19.45B
EBIT (TTM)
$9.88B
Net Income (TTM)
-$8.95B
Balance Sheet
Total Assets (Q)
$92.60B
Total Debt (Q)
$51.26B
Total Liabilities (Q)
$76.22B
Book Value Per Share (Q)
$8.05
Cash Flow
Cash from Operations (TTM)
$15.19B
Cash from Investing (TTM)
-$21.35B
Cash from Financing (TTM)
$5.13B
Net Change in Cash (TTM)
-$1.17B
Filings
Filing Date
Wednesday, February 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
0.20
7-Day Total Return
-1.35%
30-Day Total Return
-0.22%
60-Day Total Return
6.96%
90-Day Total Return
6.98%
Year to Date Total Return
5.05%
1-Year Total Return
18.04%
2-Year Total Return
-3.11%
3-Year Total Return
-4.18%
5-Year Total Return
38.29%
52-week Low
Jul 05, 2024 - $39.35
52-week High
Mar 11, 2025 - $63.33
Valuation
Market Cap
$122.33B - Large Cap
Enterprise Value
$162.46B
Price/Sales (TTM)
2.54
Price/Book (Q)
7.49
Dividends and Shares
Shares Outstanding
2.04B
Dividend Per Share (Most Recent)
$0.62
Dividend Per Share (TTM)
$2.42
Corporate Info
Website
www.bms.com
Phone Number
609 252 4621
Address
Route 206 & Province Line Road
Princeton, NJ 08543
Country
United States
Year Founded
1887
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology... more
NYSE 03/14/2025 4:00PM Eastern Quotes delayed
Weiss Ratings